Henan Taloph Pharmaceutical Stock Co (SHSE:600222) Net Change in Cash : ¥162 Mil (TTM As of Mar. 2025)

View and export this data going back to 1999. Start your Free Trial

What is Henan Taloph Pharmaceutical Stock Co Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Henan Taloph Pharmaceutical Stock Co's Net Change in Cash for the three months ended in Mar. 2025 was ¥224 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2025 was ¥162 Mil.

Henan Taloph Pharmaceutical Stock Co Net Change in Cash Historical Data

The historical data trend for Henan Taloph Pharmaceutical Stock Co's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Henan Taloph Pharmaceutical Stock Co Net Change in Cash Chart

Henan Taloph Pharmaceutical Stock Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Change in Cash

Get a 7-Day Free Trial

94.15

-157.08

-75.51

-79.72

-31.11

Henan Taloph Pharmaceutical Stock Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Change in Cash	Get a 7-Day Free Trial															30.34	78.38	45.72	-185.55	223.91

Henan Taloph Pharmaceutical Stock Co Net Change in Cash Calculation

Henan Taloph Pharmaceutical Stock Co's Net Change in Cash for the fiscal year that ended in Dec. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-39.586	+	18.251	+	-9.776	+	0
	=	-31

Henan Taloph Pharmaceutical Stock Co's Net Change in Cash for the quarter that ended in Mar. 2025

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 10.95 + 89.446 + 123.509 + 0

= 224

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥162 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Henan Taloph Pharmaceutical Stock Co Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Henan Taloph Pharmaceutical Stock Co's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Henan Taloph Pharmaceutical Stock Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Henan Taloph Pharmaceutical Stock Co Ltd (SHSE:600222) » Definitions » Net Change in Cash

Comparable Companies

SZSE:300636 SHSE:603538 SZSE:300239 SZSE:300683 SZSE:300016 SZSE:002412 SZSE:002864 SHSE:603669 SZSE:301201 SHSE:603811 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA

Traded in Other Exchanges

N/A

Address

No. 8, Jinsuo Road, High-tech Industrial Development Zone, Henan Province, Zhengzhou, CHN, 450001

Website

http://www.taloph.com

Henan Taloph Pharmaceutical Stock Co Ltd is a Chinese company engaged in the manufacture of Western and Chinese medicine products, including oral liquids, tablets, capsules, and bulk drugs. Geographically, the business activities are functioned through China region.

Executives

Zhao Qing Xin Director

Henan Taloph Pharmaceutical Stock Co Headlines

No Headlines